Abstract
An up-to-date review of biological interventions in phychoses of childhood is presented together with occasional comments on efficacy based on the author's experience. After brief mention of earlier forms of biological-organic treatment (psychosurgery, insulin, and electroconvulsive therapies), the review focuses on drug therapy. Relative prominence is given to major tranquilizers, lithium, and the hormones. Suitable information is also presented on hypnotics, anticonvulsants, sedatives, stimulants, antidepressant drugs, minor tranquilizers, hallucinogens, L-dopa, and vitamins. It is suggested that no specific drug is available for the treatment of any diagnostic category. Currently available drugs are most effective in reducing such symptoms as insomnia, hyperactivity, impulsivity, irritability, disorganized behavior, psychotic thought disorder, and certain type of aggressivity. The need for uniformity in the classification of child psychoses is stressed in light of its potential value in predicting responses of children to specific drugs.
Similar content being viewed by others
References
Ajuriaguerra, J. de.Manuel de psychiatrie de l'enfant. Paris: Masson & Cie, 1971.
Anderson, W., McC, & Dawson, J. The variability of plasma 17-hydroxycorticosteroid-levels in affective illness and schizophrenia.Psychosomatic Research, 1965,9, 237–248.
Angrist, B., Sathananthan, G., & Gershon, S. Behavioral effects of L-dopa in schizophrenic patients.Psychopharmacologia, 1973, in press.
Annell, A. Insulin shock treatment in children with psychotic disturbances.Acta Psychotherapeutica Psychoanalytica Orthopoedica, 1955,3, 193–205.
Annell, A. L. Manic-depressive illness in children and effect of treatment with lithium carbonate.Acta Paedopsychiatrica, 1969,36, 292–361. (a)
Annell, A. L. Lithium in the treatment of children and adolescents.Acta Psychiatrica Scandinavica, 1969,207 (Supp), 19–30. (b)
Anton-Tay, F., & Wurtman, R. J. Brain monoamines and endocrine function. In L. Martini & W. F. Ganong (Eds.),Frontiers in neuroendocrinology. London: Oxford University Press, 1971.
Arbit, J., Boshes, B., & Blonsky, R. Behavior and mentation changes during therapy. In A. Barbeau & F. H. McDowell (Eds.),L-dopa and Parkinsonism. Philadelphia: Davis, 1970.
Arnold, L. E., Kirilcuk, V., Corson, S. A., & Corson, E. O'L. Levoamphetamine and dextroamphetamine: Differential effect on aggression and hyperkinesis in children and dogs.American Journal of Psychiatry, 1973,130, 165–170.
Arnold, L. E., & Wender, P. H. Levoamphetamine's changing place in the treatment of children with behavior disorders.Pediatrics, 1973, in press.
Arnold, L. E., Wender, P. W., McCloskey, K., & Snyder, S. H. Levoamphetamine and dextroamphetamine: Comparative efficacy in the hyperkinetic syndrome.Archives of General Psychiatry, 1972,27, 816–822.
Balázs, R., Kovács, S., Cocks, W. A., Johnson, A. L., & Eayrs, J. T. Effect of thyroid hormone on the biochemical maturation of rat brain: Postnatal cell formation.Brain Research, 1971,25, 555–570.
Ban, T. A. Nicotinic acid in psychiatry.Canadian Psychiatric Association Journal, 1971,16, 413–431.
Ban, T. A., & Lehmann, H. E.Nicotinic acid in the treatment of schizophrenias. Progress Report I. Toronto: Canadian Mental Health Association, 1970.
Bender, L. One hundred cases of childhood schizophrenia treated with electric shock.Transactions of the American Neurological Association, 1947,72, 165–169.
Bender, L., Cobrinik, L., Faretra, G., & Sankar, D. V. S. The treatment of childhood schizophrenia with LSD and UML. In M. Rinkel (Ed.),Biological treatment of mental illness, New York: L. C. Page & Co., 1966.
Bender, L., & Cottington, F. The use of amphetamine sulfate (Benzedrine) in child psychiatry.A merican Journal of Psychiatry, 1942,99, 116–121.
Bender, L., Goldschmidt, L., & Sankar, D. V. S. Treatment of autistic schizophrenic children with LSD-25 and UML-491. In J. Wortis (Ed.),Recent advances in biological psychiatry. New York: Plenum Press, 1962.
Bender, L., Faretra, G., & Cobrinik, L. LSD and UML treatment of hospitalized disturbed children. In J. Wortis (Ed.),Recent advances in biological psychiatry, New York: Plenum Press, 1963.
Bender, L., & Keeler, W. R. The body image of schizophrenic children following electroshock therapy.American Journal of Orthopsychiatry, 1952,22, 335–355.
Bender, L., & Nichtern, S. Chemotherapy in child psychiatry.New York State Journal of Medicine, 1956,56, 2791–2795.
Boullin, D. J., Coleman, M., & O'Brien, R. A. Abnormalities in platelet 5-hydroxytryptamine efflux in patients with infantile autism.Nature, 1970,226, 371–372.
Boullin, D. J., Coleman, M., O'Brien, R. A., & Rimland, B. Laboratory predictions of infantile autism based on 5-HT efflux from platelets and their correlation with the Rimland E-2 score.Journal of Autism and Childhood Schizophrenia, 1971,1, 63–71.
Bradley, C. The behavior of children receiving benzedrine.American Journal of Psychiatry, 1937,94, 577–585.
Bradley, C., & Bowen, M. Amphetamine (benzedrine) therapy of children's behavior disorders.American Journal of Orthopsychiatry, 1941,11, 92–103.
Brambilla, F., & Penati, G. Hormones and behavior in schizophrenia. In D. H. Ford (Ed.),Influence of hormones on the nervous system. Basel: Karger, 1971.
Butcher, L. L., Engel, J., & Fuxe, K. L-dopa induced changes in central monoamine neurons after peripheral decarboxylase inhibition.Journal of Pharmacy and Pharmacology, 1970,22, 313–316.
Burk, H. W., & Menolascino, F. J. Haloperidol in emotionally disturbed mentally retarded individuals.American Journal of Psychiatry, 1968,124, 1589–1591.
Campbell, J. D. Manic-depressive disease in children.Journal of the American Medical Association, 1955,198, 154–157.
Campbell, M. A psychotic boy with self mutilating behavior and the antiaggressive effect of lithium.Journal of the American Academy of Child Psychiatry, 1973, in press.
Campbell, M., Fish, B., Shapiro, T., & Floyd, A., Jr. Thiothixene in young disturbed children. A pilot study.Archives of General Psychiatry, 1970,23, 70–72.
Campbell, M., Fish, B., Shapiro, T., & Floyd, A., Jr. Study of molindone in disturbed preschool children.Current Therapeutic Research, 1971,13, 28–33. (a)
Campbell, M., Fish, B., Shapiro, T., & Floyd, A., Jr. Imipramine in preschool autistic and schizophrenic children.Journal of Autism and Childhood Schizophrenia, 1971,1, 267–282. (b)
Campbell, M., Fish, B., David, R., Shapiro, T., Collins, P., & Koh, C. Response to triiodothyronine and dextroamphetamine: A study of preschool schizophrenic children.Journal of Autism and Childhood Schizophrenia, 1972,2, 343–358. (a)
Campbell, M., Fish, B., Korein, J., Shapiro, T., Collins, P., & Koh, C. Lithium-chlorpromazine: A controlled crossover study in hyperactive severely disturbed young children.Journal of Autism and Childhood Schizophrenia, 1972,2, 234–263. (b)
Campbell, M., Fish, B., Shapiro, T., & Floyd, A., Jr. Acute responses of schizophrenic children to a sedative and “stimulating” neuropletic: A pharmacologic yardstick.Current Therapeutic Research, 1972,14, 759–766. (c)
Campbell, M., Fish, B., David, R., Shapiro, T., Collins, P., & Koh, C. Liothyronine treatment in psychotic and nonpsychotic childre'n under six years.Archives of General Psychiatry, 1973, in press.
Campbell, M., Friedman, E., DeVito, E., Greenspan, L., & Collins, P. J. Blood serotonin in disturbed and brain damaged children.Journal of Autism and Childhood Schizophrenia, 1973, in press.
Campbell, M., & Hersh, S. P. Observations on the vicissitudes of aggression in two siblings.Journal of Autism and Childhood Schizophrenia, 1971,1, 398–410.
Cerletti, V. Old and new information about electroshock.American Journal of Psychiatry, 1950,107, 87–94.
Cleckley, H. M., Sydenstricker, V. P., & Geeslin, L. E. Nicotinic acid in the treatment of atypical psychotic states.Journal of the American Medical Association, 1939,112, 2107–2110.
Coleman, M. Serotonin levels in infant hypothyroidism.Lancet, 1970,2, 365.
Coleman, M. Serotonin and central nervous system syndromes in childhood: A review.Journal of Autism and Childhood Schizophrenia, 1973,3, 27–35.
Coleman, M., Campbell, M., Freedman, L. S., Roffman, M., Ebstein, R. P., & Goldstein, M. Serum dopamine-B-hydroxylase levels in Down's syndrome.Clinical Genetics, 1973, in press.
Corson, S. A., Corson, E. O'L., Kirilcuk, V., Knopp, W., & Arnold, L. E. Differential interaction of amphetamines and psychosocial factors in the modification of violent and hyperkinetic behavior and learning disability.Federal Proceedings, 1972,31, 820.
Danziger, L. Thyroid therapy of schizophrenia.Diseases of the Nervous System, 1958,19, 373–378.
Danziger, L., & Kindwall, J. A. Thyroid therapy in some mental disorders.Diseases of the Nervous System, 1953,14, 3–13.
Dostal, T. Antiaggressive effect of lithium salts in mentally regarded adolescents. In A. L. Annell (Ed.),Depressive states in childhood and adolescence. Stockholm: Almquist & Wiksell, 1972.
Durell, J., Libow, L. S., Kellam, S. G., & Shader, R. I. Interrelationships between regulation of thyroid gland function and psychosis.Association for Research in Nervous and Mental Diseases, 1963,43, 387–399.
Dyson, W. L., & Barcai, A. Treatment of children of lithium-responding parents.Current Therapeutic Research, 1970,12, 286–290.
Eayrs, J. T. Developmental relationships between brain and thyroid. In R. P. Michael (Ed.),Endocrinology and human behavior. Oxford University Press, 1968.
Effron, A. S., & Freedman, A. M. The treatment of behavior disorders in children with benadry 1.Journal of Pediatrics, 1953,42, 261–266.
Engelhardt, D. M., Polizos, P., & Margolis, R. A. The drug treatment of childhood psychosis. In W. L. Smith (Ed.),Drugs, development and cerebral function. Springfield, Ill.: Charles C Thomas, 1972.
Engelhardt, D. M., Polizos, P., Waizer, J., & Hoffman, S. P. A double-blind comparison of fluphenazine and haloperidol in outpatient schizophrenic children.Journal of Autism and Childhood Schizophrenia, 1973,3, 128–137.
Everett, G. M., & Borcherding, J. W. L-dopa: Effect on concentrations of dopamine, norepinephrine and serotonin in brains of mice.Science, 1970,168, 849–850.
Feldmesser-Reiss, E. E. The application of triiodothyronine in the treatment of mental disorders.Journal of Nervous and Mental Disease, 1958,127, 540–545.
Fish, B. Drug therapy in child psychiatry: Pharmacological aspects.Comprehensive Psychiatry, 1960,1, 212–227.
Fish, B. The influence of maturation and abnormal development on the responses of disturbed children to drugs.Proceedings of the Third World Congress of Psychiatry, 1963.
Fish, B. Drug use in psychiatric disorders in children.American Journal of Psychiatry, 1968,124, 31–36.
Fish, B. Psychopharamcologic responses of chronic schizophrenic adults as predictors of responses in young schizophrenic children.Psychopharmacology Bulletin, 1970,6, 12–15.
Fish, B. The “one child, one drug” myth of stimulants in hyperkinesis. Importance of diagnostic categories in evaluating treatment.Archives of General Psychiatry, 1971,25, 193–203.
Fish, B., Campbell, M., Shapiro, T., & Floyd, A., Jr. Comparison of trifluperidol, trifluoperazine and chlorpromazine in preschool schizophrenic children: The value of less sedative antipsychotic agents.Current Therapeutic Research, 1969,11, 589–595. (a)
Fish, B., Campbell, M., Shapiro, T., & Floyd, A., Jr. Schizophrenic children treated with methysergide (Sansert).Diseases of the Nervous System, 1969,30, 534–540. (b)
Fish, B., Campbell, M., Shapiro, T., & Weinstein, J. Preliminary findings on thiothixene compared to other drugs in psychotic children under five years. In H. E. Lehmann & T. A. Ban (Eds.),The thioxanthenes: Modern problems of pharmacopsychiatry. Vol. 2. Basel, Switzerland: S. Karger, 1969. (c)
Fish, B., Shapiro, T., & Campbell, M. Long-term prognosis and the response of schizophrenic children to drug therapy: A controlled study of trifluoperazine.American Journal of Psychiatry, 1966,123, 32–39.
Fox, W., Gobble, I. F., Clos, M., & Denison, E. A clinical comparison of trifluperidol, haloperidol and chlorpromazine.Current Therapeutic Research, 1964,6, 409–415.
Freedman, A. M., Ebin, E. V., & Wilson, E. A. Autistic schizophrenic children. An experiment in the use of D-lysergic acid diethylamide (LSD-25).Archives of General Psychiatry, 1962,6, 203–213.
Freeman, W. Psychosurgery. In S. Arieti (Ed.),American handbook of psychiatry, Vol. II. New York: Basic Books, 1959.
Frommer, E. Depressive illness in childhood. In A. Coppen & A Walk (Eds.),Recent developments in affective disorders. A Symposium. British Journal of Psychiatry, 1968, Special Publication No.2, 117–136.
Gallant, D. M., & Bishop, M. P. Molindone: A controlled evaluation in chronic schizophrenic patients.Current Therapeutic Research, 1968,10, 441–447.
Gallant, D. M., Bishop, M. P. Nesselhoff, W., Jr., & Sprehe, D. J. Further observations on trifluperidol: A butyrophenone derivative.Psychopharmacologia, 1965,7, 37–43.
Gallant, D. M., Bishop, M. P., & Shelton, W. A preliminary evaluation of P-4657B: A thioxanthene derivative.American Journal of Psychiatry, 1966,123, 345–346.
Gallant, D. M., Bishop, M. P., Timmons, E., & Gould, A. R. Thiothixene (P-4657B): A controlled evaluation in chronic schizophrenic patients.Current Therapeutic Research, 1966,8, 153–158.
Gershon, S., Holmberg, G., Mattson, E., & Marshall, A. Imipramine hydrochloride. Its effects on clinical, autonomic and psychological functions.Archives of General Psychiatry, 1962,6, 96–101.
Gjessing, R. Beiträge zur Kenntniss der Pathophysiologie des katatonen Stupors.Archive für Psychiatrie und Nervenkrankheiten, 1932,96, 319–392.
Gjessing, R. Disturbances of somatic functions in catatonia with a periodic course, and their compensation.Journal of Mental Science, 1938,84, 608–621.
Gjessing, R. Beiträge zur Somatologie der periodischen Katatonie.Archive für Psychiatrie und Zeitschrift Neurologie, 1953,191, 191–326.
Goodwin, F. K., Murphy, D. L., Brodie, H. K. H., & Bunney, W. E. L-dopa, catecholamines, and behavior: A clinical and biochemical study in depressed patients.Biological Psychiatry, 1970,3, 341–366.
Gram, L. F., & Rafaelsen, O. J. Lithium treatment of psychotic children and adolescents. A controlled clinical trial.Acta Psychiatrica Scandinavica, 1972,48, 253–260.
Greenbaum, G. H. An evaluation of niacinamide in the treatment of childhood schizophrenia.American Journal of Psychiatry, 1970,127, 129–132.
Gurewitz, S., & Helme, W. H. Effects of electroconvulsive therapy on personality and intellectual functioning of the schizophrenic childJournal of Nervous and Mental Disease, 1954,120, 213–226.
Heuyer, G., Lang, J. L., & Rivaille, C. J. Aspects cliniques des schizophrenies traitees par l'insuline.Revue de Neuropsychiatrie Infantile et d'Hygiene Mentale de l'Enfance, 1956,4, 390–396.
Himwich, H. E., Kety, S. S., & Smythies, J. R.Amines and schizophrenia. New York: Pergamon Press, 1967.
Hoffer, A. Mechanisms of action of nicotinic acid and nicotinamide in the treatment of schizophrenia. In D. Hawkins & L. Pauling (Eds.),Orthomolecular psychiatry. San Francisco: W. H. Freeman, 1973.
Hoffer, A. Childhood schizophrenia: A case treated with nicotinic acid and nicotinamide.Schizophrenia, 1970,2, 43–53.
Hoskins, R. G.The biology of schizophrenia. New York: Norton & Co., 1946.
Kety, S. S. Toward hypotheses for a biochemical component in the vulnerability to schizophrenia.Seminars in Psychiatry, 1972,4, 233–238.
Klein, D., & Fink, M. Psychiatric reaction to imipramine.American Journal of Psychiatry, 1962,119, 432–438.
Kraft, I. A., Ardali, C., Duffy, J. H., Hart, J. T., & Pearce, P. A clinical study of chlordiazepoxide used in psychiatric disorders of children.International Journal of Neuropsychiatry, 1965,1, 433–437.
Krantz, J. C., Jr., Truitt, E. B., Jr., Speers, L., & Ling, A. S. O. New pharmacoconvulsive agent.Science, 1957,126, 353.
Kurtis, L. B. Clinical study of the response to nortriptyline on autistic children.International journal of Neuropsychiatry, 1966,2, 298–301.
Lapin, I. P., & Oxenkrug, G. F. Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect.Lancet, 1969,1, 132–136.
LaVeck, G. D., & Buckley, P. The use of psychopharmacologic agents in retarded children with behavior disorders.Journal of Chronic Diseases, 1961,13, 174–183.
LeVann, L. J. Chlordiazepoxide, a tranquilizer with anticonvulsant properties.Canadian Medical Association Journal, 1962,86, 123–126.
LeVann, L. J. Haloperidol in the treatment of behavioural disorders in children and adolescents.Canadian Psychiatric Association Journal, 1969,14, 217–220.
Lipton, M. A., Ban, T. A., Kane, F. J., Levine, J., Mosher, L. R., & Wittenborn, R.Megavitamin and orthomolecular therapy in psychiatry. Washington, D.C.: American Psychiatric Association, 1973.
Loranger, A. W., Goodell, H., Lee, J. H., & McDowell, F. Levo-dopa treatment of Parkinson's syndrome. Improved intellectual functioning.Archives of General Psychiatry, 1972,26, 163–168.
McCann, S. Mechanism of action of hypothalamic-hypophyseal stimulating and inhibiting hormones. In L. Martini & W. F. Ganong (Eds.),Frontiers in neuroendocrinology. London: Oxford University Press, 1971.
McGrath, S. D., O'Brien, P. F., Power, P. J., & Shea, J. R. Nicotinamide treatment of schizophrenia. Report of a multi-hospital controlled trial.Schizophrenia Bulletin, 1972, No. 5, 74–76.
Moniz, E.Tentative operatoires dans le traitement de certaines psychoses. Paris: Masson et Cie, 1936.
Mosher, L. R. Nicotinic acid side effects and toxicity. A review.American Journal of Psychiatry, 1970,126, 1290–1296.
Murphy, D. L. L-dopa, behavioral activation and psychopathology. In I. J. Kopin (Ed.),Neurotransmitters. Baltimore: Williams & Wilkins, 1972. (a)
Murphy, D. L. Amine precursors, amines and false neurotransmitters in depressed patients.American Journal of Psychiatry, 1972,129, 141–148. (b)
Ny, K. Y., Chase, T. N., Colburn, R. W., & Kopin, K. J. L-dopa-induced release of cerebral monoamines.Science, 1970,170, 76–77.
O'Brien, C. P., DiGiacomo, J. N., Fahn, S., & Schwarz, G. A. Mental effects of high-dosage levodopa.Archives of General Psychiatry, 1971,24, 61–64.
Osmond, H., & Hoffer, A. Massive niacin treatment in schizophrenia. Review of a nine-year study.Lancet, 1962,1, 316–319.
Osmond, H. The background to the niacin treatment. In D. Hawkins & L. Pauling (Eds.),Orthomolecular psychiatry. San Francisco: W. H. Freeman, 1973.
Pauling, L. Orthomolecular psychiatry.Science, 1968,160, 265–271.
Persky, H., Zuckerman, M., & Curtis, G. C. Endocrine function in emotionally disturbed and normal men.Journal of Nervous and Mental Disease, 1968,146, 488–497.
Pilkington, T. L. Comparative effects of librium and taractan on behavior disorders of mentally retarded children.Diseases of the Nervous System, 1961,22, 573–575. (a)
Pilkington, T. L. The effects of librium and taractan on the behavior of psychotically disturbed mentally retarded children.Psychopharmacology Abstracts, 1961,61, 572. (b)
Pollack, M., Klein, D. F., Willner, A., Blumberg, A., & Fink, M. Imipramine-induced behavioral disorganization in schizophrenic patients: Physiological and psychological correlates. In J. Wortis (Ed.),Recent advances in biological psychiatry. New York: Plenum Press, 1965.
Prange, A. J., Jr., Wilson, I. C., Rabon, A. M., & Lipton, M. A. Enhancement of imipramine antidepressant activity by thyroid hormone.American Journal of Psychiatry, 1969,126, 457–469.
Prange, A. J., Jr., & Lipton, M. A. Hormones and behavior: Some principles and findings. In R. I. Shader (Ed.),Psychiatric complications of medical drugs. New York: Raven Press, 1972.
Ramsey, R. A., Ban, T. A., Lehmann, H. E., Saxena, B. M., & Bennett, J. Nicotinic acid as adjuvant therapy in newly admitted schizophrenic patients.Canadian Medical Association Journal, 1970,102, 939–942.
Reiss, M. Correlations between changes in mental states and thyroid activity after different forms of treatment.Journal of Mental Sciences, 1954,100, 687–703.
Reiss, M. (Ed.)Psychoendocrinology. New York: Grune & Stratton, 1958.
Reiss, M. Clinical and basic neuroendocrine investigations in some states of mental retardation. In D. H. Ford (Ed.),Influence on hormones on the nervous system. Basel: Karger, 1971.
Rimland, B. High-dosage levels of certain vitamins in the treatment of children with severe mental disorders In D. Hawkins & L. Pauling (Eds.),Orthomolecular psychiatry. San Francisco: W. H. Freeman, 1973.
Rolo, A., Krinsky, L., Abramson, H., & Goldfarb, L. Preliminary method study of LSD with children.International Journal of Neuropsychiatry, 1965,1, 552–555.
Ritvo, E. R., Yuwiler, A., Geller, E., Ornitz, E. M., Saeger, K., & Plotkin, S. Increased blood serotonin and platelets in early infantile autism.Archives of General Psychiatry, 1970,23, 566–572.
Ritvo, E. R., Yuwiler, A., Geller, E., Kales, A., Rashkis, S., Schicor, A., Plotkin, S., Axelrod, R., & Howard, C. Effects of L-dopa in autism.Journal of Autism and Childhood Schizophrenia, 1971,1, 190–205.
Sachar, E. J. Psychoendocrine aspects of acute schizophrenic reactions.Psychosomatic Medicine, 1963,25, 510–537.
Sachar, E. J., Harmatz, J., Bergen, H., & Cohler, J. Corticosteroid responses to milieu therapy of chronic schizophrenics.Archives of General Psychiatry, 1966,15, 310–319.
Sachar, E. J., Hellman, L., Roffwarg, H. P., Halpern, F. S., Fukushima, D. K., & Gallagher, T. F. Disrupted 24-hour patterns of cortisol secretion in psychotic depression.Archives of General Psychiatry, 1973,28, 19–24.
Sakel, M.The pharmacological shock treatment of schizophrenia. New York: Nervous and Mental Diseases Publishing Co., 1938.
Schain, R. J., & Freedman, D. X. Studies of 5-hydroxyindole metabolism in autistic and other mentally retarded children.Journal of Pediatrics, 1961,58, 315–320.
Schapiro, S. Influence of hormones and environmental stimulation of brain development. In D. H. Ford (Ed.),Influence of hormones on the nervous system. Basel: S. Karger, 1971.
Sheard, M. H. Effect of lithium on foot shock aggression in rats.Nature, 1970,228, 284–285. (a)
Sheard, M. H. Behavioral effects of p-chlorophenylalanine in rats: Inhibition by lithium.Communications in Behavioral Biology, 1970,5, 71–73. (b)
Sheard, M. H. Effect of lithium on human aggression.Nature, 1971,230, 113–114. (a)
Sheard, M. The effect of lithium on behavior.Communications in Contemporary Psychiatry, 1971,1, 1–6. (b)
Sherwin, A. C., Flach, F. F., & Stokes, P. E. Treatment of psychoses in early childhood with triiodothyronine.American Journal of Psychiatry, 1958,115, 166–167.
Schildkraut, J. J., & Kety, S. S. Biogenic amines and emotion. Pharmacological studies suggest a relationship between brain biogenic amines and affective state.Science, 1967,156, 21–30.
Schou, M. Lithium in psychiatric therapy and prophylaxis. A review with special regard to its use in children. In A. L. Annell (Ed.),Depressive states in childhood and adolescence. Stockholm: Almquist & Wiksell, 1972.
Silver, A. A. Management of children with schizophrenia.American Journal of Psychotherapy, 1955,9, 196–215.
Simeon, J., Saletu, B., Saletu, M., Itil, T. M., & DaSilva, J. Thiothixene in childhood psychoses. Paper presented at the Third International Symposium on Phenothiazines, Rockville, Maryland, 1973.
Simmons, J. Q., III, Leiken, S. J., Lovaas, O. I., Schaeffer, B., & Perloff, B. Modification of autistic behavior with LSD-25.American Journal of Psychiatry, 1966,122, 1201–1211.
Simpson, G. M., Cranswick, E. H., & Blair, J. H. Thyroid indices in chronic schizophrenia.Journal of Nervous and Mental Disease, 1963,137, 582–590.
Simpson, G. M., Cranswick, E. H., & Blair, J. H. Thyroid indices in chronic schizophrenia: II.Journal of Nervous and Mental Disease, 1964,138, 581–585.
Simpson, G. M., & Igbal, J. A preliminary study of thiothixene in chronic schizophrenics.Current Therapeutic Research, 1965,7, 310–314.
Simpson, G. M., & Krakov, L. A preliminary study of molindone (EN-1733A) in chronic schizophrenia.Current Therapeutic Research, 1968,10, 41–46.
Skynner, A. C. R. Effect of chlordiazepoxide.Lancet, 1961,1, 1110.
Snyder, S. H., Taylor, K. M., Coyle, J. T., & Meyerhoff, J. L. The role of brain dopamine in behavioral regulation and the actions of psychotropic drugs.American Journal of Psychiatry, 1970,127, 199–207.
Sokoloff, L., & Roberts, P. Biochemical mechanism of the action of thyroid hormones in nervous and other tissues. In D. H. Ford (Ed.),Influence of hormones on the nervous system. Basel: Karger, 1971.
Sugerman, A. A., Stolberg, H., & Herrmann, J. A pilot study of P-4657B in chronic schizophrenics.Current Therapeutic Research, 1965,7, 310–314.
Sugerman, A. A., & Herrmann, J. Molindone: An indole derivative with anti-psychotic activity.Clinical Pharmacology and Therapeutics, 1967,8, 261–265.
Taylor, K. M., & Snyder, S. H. Amphetamine: Differentiation by D- and L-isomers of behavior involving brain norepinephrine or dopamine.Science, 1970,168, 1487–1489.
Tupin, J. P., & Smith, D. B. The long-term use of lithium in aggressive prisoners. Paper presented at the Meeting of the Early Clinical Drug Evaluation Unit, Psychopharamacology Research Branch, NIMH, Catonsville, Maryland, June 1972.
Waizer, J., Polizoes, P., Hoffman, S. P., Engelhardt, D. M., & Margolis, R. A. A single-blind evaluation of thiothixene with outpatient schizophrenic children.Journal of Autism and Childhood Schizophrenia, 1972,2, 378–386.
Weischer, M. L. On the antiaggressive effect of lithium.Psychopharmacologia, 1969,15, 245–254.
Whitehead, P. L., & Clark, L. D. Effect of lithium carbonate, placebo and thioridazine on hyperactive children.American Journal of Psychiatry, 1970,127, 824–825.
Williams, J. M., & Freeman, W. Evaluation of lobotomy with special reference to children. Association for Research in Nervous and Mental Disease, Proceedings, 1953,31, 311.
Wilson, M. B., Prange, A. J., Jr., McClane, T. K., Rabon, A. M., & Lipton, M. A. Thyroid hormone enhancement of imipramine in nonretarded depressions.New England Journal of Medicine, 1970,282, 1063–1067.
Wilson, I. C., Prange, A. J., Jr., & Lara, P. P. T3 alone in depressed adults. Paper presented at the Annual Meeting of the American College of Neuropsychopharmacology, San Juan, Puerto Rico, December 1972.
Wittenborn, J. R., Weber, E. S. P., & Brown, M. Niacin in the long-term treatment of schizophrenia.Archives of General Psychiatry, 1973,28, 308–315.
Author information
Authors and Affiliations
Additional information
Paper to be read on November 1, 1973 at the First International Leo Kanner Colloquium on Child Development, Deviations and Treatment, Chapel Hill, N.C. Part of the work was supported by Public Health Service Grant MH-04665 from the National Institute of Mental Health. The author wishes to thank Mrs. Loren Wissner Greene for her assistance in the literature search.
Rights and permissions
About this article
Cite this article
Campbell, M. Biological interventions in psychoses of childhood. J Autism Dev Disord 3, 347–373 (1973). https://doi.org/10.1007/BF01538542
Issue Date:
DOI: https://doi.org/10.1007/BF01538542